Administrative Core

行政核心摘要 一个有效的行政结构是必不可少的设计和实施的TUCAIN U 54中心。 管理核心将专注于促进沟通，协作，规划，数据共享， 对TUCAIN内的共享资源核心和研究项目进行科学和财务监督。通过 作为管理核心，我们将监督中心的所有目标，并确保其成功，成本效益和及时 建成管理核心将协调、安排和实施每月的内部电话会议 中心参与者之间的会议，并将协助核心和项目的PI准备 进度报告、内部合规文件和支持TUCAIN总体目标的手稿。 管理核心将负责以下具体目标：（1）创建一个管理，沟通 和领导结构。(2)在以下人员之间提供有效和响应迅速的沟通渠道： TUCAIN成员，NIH和SeroNet的其他成员。(3)确保项目和核心的完全集成 在图凯恩。(4)协助核心和项目PI进行行政方面的工作。(5)与其它 SeroNet的成员，以促进合作和协调。(6)提供每个核心和项目 TUCAIN具有强大的集成数据管理和统计支持。(7)协调定期评价 TUCAN和参与指导委员会，以确保该计划是成功的，其总体目标是 了解对SARS-CoV-2的免疫反应。

Administrative Core Summary An efficient administrative structure is essential to the design and implementation of the TUCAIN U54 Center. The Admin Core will be focused on facilitating communication, collaboration, planning, data sharing, and scientific and financial oversight of the Shared Resource Cores and Research Projects within TUCAIN. Through the Admin Core, we will oversee all the goals of the Center and ensure their successful, cost-effect, and timely completion. The Admin Core will coordinate, schedule, and implement monthly internal teleconferencing meetings among the Center participants, and will assist the PIs of the Cores and Projects in the preparation of progress reports, internal compliance filings, and manuscripts to support the overall goals of TUCAIN. The Admin Core will be responsible for the following Specific Aims: (1) Create an administrative, communication and leadership structure for TUCAIN. (2) Provide an effective and responsive line of communication between TUCAIN members, the NIH, and other members of SeroNet. (3) Ensure the full integration of Projects and Cores within TUCAIN. (4) Assist Core and Project PIs with administrative aspects. (5) Communicate with other members of SeroNet to facilitate collaboration and coordination. (6) Provide each Core and Project under TUCAIN with robust, integrated data management and statistical support. (7) Coordinate periodic evaluation of TUCAN and engage the Steering Committee to ensure the program is successful in its overarching goal of understanding immune responses to SARS-CoV-2.